Breadcrumb

CORE News

Three COVID-19 projects at the RI-MUHC to receive CIHR funding

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

COVID-19 pandemic: Looking back to better tackle future challenges

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper

A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis

COVID-19 pandemic: the need for privacy and digital contact tracing

RI-MUHC researcher Abhinav Sharma calls for an approach emphasizing voluntary consent

Innovation Moves Online for the 2020 McGill Clinical Innovation Competition

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

Why do some non-smokers get COPD while many heavy smokers don’t?

A new study highlights a strong risk factor for COPD related to lung development

Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

Results of MI4 Emergency COVID-19 Research Funding (Round 2)

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

National study to collect data on aging adults’ experiences during COVID-19 pandemic

Christina Wolfson is co-principal investigator on a new national study

Explore news and events at the RI-MUHC